Revenue and Profit - The company's revenue for the current reporting period reached ¥385,431,561.25, representing a year-over-year increase of 356.13% due to the consolidation of Wuhan Junheng[3][4] - Net profit attributable to shareholders increased by 6.80% year-over-year to ¥14,204,649.38, driven by a 51% profit contribution from Wuhan Junheng[3][4] - The net profit attributable to shareholders after deducting non-recurring gains and losses grew by 91.09% to ¥12,455,639.71, primarily due to the timing of government subsidies[3][4] - Total operating revenue for the current period reached ¥1,081,272,403.51, a significant increase from ¥353,185,925.24 in the previous period, representing a growth of approximately 206%[24] - Net profit for the current period was ¥97,496,000.55, up from ¥26,434,742.88 in the previous period, reflecting a growth of approximately 269%[25] - The total comprehensive income for the current period was ¥97,364,627.73, compared to ¥26,434,742.88 in the previous period, indicating an increase of approximately 268%[26] Assets and Liabilities - Total assets increased by 47.51% to ¥4,048,281,087.58, largely as a result of the consolidation of Wuhan Junheng[3][4] - Total liabilities increased to ¥2,120,155,914.66 from ¥1,179,634,082.52, representing a growth of approximately 80%[23] - Total equity rose to ¥1,928,125,172.92, compared to ¥1,564,837,118.27 in the previous period, indicating an increase of about 23%[23] - Current assets totaled ¥3,319,776,213.75 CNY, compared to ¥2,214,036,494.30 CNY previously, reflecting a substantial increase[21] Cash Flow - Cash received from sales and services rose by 208.68% to ¥1,032,933,355.42 compared to ¥334,629,218.94, driven by the consolidation of Wuhan Junheng[10] - Total cash inflow from operating activities increased by 178.01% to ¥1,080,224,557.06 from ¥388,562,182.13, also due to the consolidation of Wuhan Junheng[10] - Operating cash inflow totaled $1,080,224,557.06, compared to $388,562,182.13 in the previous period, indicating a significant increase[29] - The net increase in cash and cash equivalents was -$84,059,681.34, compared to -$69,521,856.31 in the prior period[29] - The ending balance of cash and cash equivalents stood at $191,879,072.98, up from $172,196,517.18[29] Expenses - Research and development expenses surged by 751.69% to ¥30,343,503.99, reflecting increased investment in innovation following the acquisition[9] - Total operating costs amounted to ¥995,567,321.39, compared to ¥329,548,682.21 in the prior period, indicating an increase of about 202%[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 33,787[13] - The company adjusted the grant price for the 2025 restricted stock incentive plan from 4.60 CNY/share to 4.55 CNY/share, granting a total of 1 million shares[18] - The total number of shares increased from 784,164,678 to 785,164,678 after the completion of the restricted stock grant[19] Acquisition and Restructuring - The company plans to acquire a 49% stake in Wuhan Junheng Technology Co., Ltd. through a combination of issuing shares and cash payments, constituting a major asset restructuring[14] - The company has signed a framework agreement for the acquisition of assets, leading to a stock suspension starting July 22, 2025[15] - The board approved the asset acquisition and fundraising plan on July 25, 2025, with independent directors providing their review opinions[16] - As of the report date, the application for the asset acquisition and fundraising has been accepted by the Shenzhen Stock Exchange[17]
汇绿生态(001267) - 2025 Q3 - 季度财报